血清淀粉样蛋白A联合多配体蛋白聚糖-1对脓毒症所致急性呼吸窘迫综合征病情评估及预后预测价值分析

Evaluation of serum amyloid A combined with polyligand proteosan-1 in patients with acute respiratory distress syndrome caused by sepsis and predictive value for prognosis

  • 摘要:
    目的 分析血清淀粉样蛋白A(SAA)联合多配体蛋白聚糖-1(SDC-1)对脓毒症所致急性呼吸窘迫综合征病情评估及预后预测价值。
    方法 选择158例脓毒症所致急性呼吸窘迫综合征患者为研究对象,根据柏林定义将患者分为轻中度组氧合指数(OI)>100 mmHg和重度组(OI≤100 mmHg)。检测所有患者血清SAA、SDC-1表达水平,分析患者血清SAA、SDC-1表达水平与OI的关系。同时,根据患者肺水肿严重程度不同,将158例脓毒症所致急性呼吸窘迫综合征患者分为轻度肺水肿组(血管外肺水指数≤10 mL/kg)和重度肺水肿组(血管外肺水指数>10 mL/kg), 比较不同肺水肿程度患者血清SAA、SDC-1表达水平。观察脓毒症所致急性呼吸窘迫综合征患者28 d后预后情况,并根据预后结果分为病死组与存活组。使用受试者工作特征(ROC)曲线分析血清SAA联合SDC-1预测脓毒症所致急性呼吸窘迫综合征患者病死的效能。
    结果 重度组血清SAA、SDC-1表达水平均高于轻中度组,差异有统计学意义(P < 0.05); 经Pearson相关性分析,脓毒症所致急性呼吸窘迫综合征患者血清SAA、SDC-1表达水平与OI呈负相关(r=-0.951、-0.967, P < 0.05); 重度肺水肿组血清SAA、SDC-1表达水平均高于轻度肺水肿组,差异有统计学意义(P < 0.05); 158例脓毒症所致急性呼吸窘迫综合征患者中,治疗28 d后死亡36例,占22.78%; 病死组治疗前及治疗72 h血清SAA、SDC-1表达水平均高于存活组,差异有统计学意义(P < 0.05); 经ROC曲线分析,血清SAA联合SDC-1预测脓毒症所致急性呼吸窘迫综合征患者病死的敏感度为92.48%、特异度为68.09%, ROC曲线下面积(AUC)为0.918。
    结论 血清SAA、SDC-1与脓毒症所致急性呼吸窘迫综合征病情严重程度有关,两者联合预测的预后不良效能较好,值得进一步研究应用。

     

    Abstract:
    Objective To analyze the value of serum amyloid A(SAA) combined with polyligand proteosan-1(SDC-1) in the assessment of disease conditions and in predicting prognosis of acute respiratory distress syndrome caused by sepsis.
    Methods A total of 158 patients with acute respiratory distress syndrome due to sepsis were selected as study subjects. According to the Berlin definition, the patients with acute respiratory distress syndrome were divided into mild to moderate groupoxygenation index(OI)>100 mmHg and severe group (OI≤100 mmHg). The expression levels of SAA and SDC-1 in serum of all patients were detected, and the relationships of the expression levels of SAA and SDC-1 with OI in patients with acute respiratory distress syndrome were analyzed. According to the severity of pulmonary edema, 158 patients with acute respiratory distress syndrome caused by sepsis were divided into mild pulmonary edema group (extravascular pulmonary edema edema ≤10 mL/kg) and severe pulmonary edema group (extravascular pulmonary edema edema >10 mL/kg), and the expression levels of SAA and SDC-1 in serum of patients with different degrees of pulmonary edema were compared. The prognosis of patients with acute respiratory distress syndrome after 28 days was observed and they were divided into death group and survival group according to prognosis results. The predictive efficacy of serum SAA combined with SDC-1 in predicting death of patients with acute respiratory distress syndrome was analyzed by receiver operating characteristic curve(ROC).
    Results The serum levels of SAA and SDC-1 in the severe group were higher than those in mild and moderate group, and the difference was significant(P < 0.05). Pearson correlation analysis showed that the expression levels of SAA and SDC-1 in the serum of patients with acute respiratory distress syndrome were negatively correlated with OI(r=-0.951 and -0.967, P < 0.05). The levels of SAA and SDC-1 in severe pulmonary edema group were higher than those in mild pulmonary edema group (P < 0.05). Among 158 patients with acute respiratory distress syndrome, 36(22.78%) died after 28 days of treatment. The expression levels of SAA and SDC-1 in serum of the death group were higher than those of the survival group before treatment and 72 h after treatment (P < 0.05). According to ROC curve analysis, the sensitivity and specificity of serum SAA combined with SDC-1 to predict death in patients with acute respiratory distress syndrome were 92.48% and 68.09%, and the area under ROC curve(AUC) was 0.918.
    Conclusion Serum SAA and SDC-1 are related to the severity of acute respiratory distress syndrome caused by sepsis, the combined effect of SAA and SDC-1 is better in predicting poor prognosis, which is worthy of further study and application.

     

/

返回文章
返回